Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room: Disposals of own shares

INFORMATION REGLEMENTEE


[20/11/2020 | 20:05]
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6ek0LDXk2-2B8BHiyhda-2BoCOnZpto1l2utuychrj-2BBiu37OJmyXv=
hpDnBwVvYY-2BbmXbpk3OD8Z-2Fj8c7qof-2FX5erglz-76z_xDPID0vOuylFAU8fv4e60wei4J=
xqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj=
-2F2X9c9g1waQrs7SsLCPjFrUGj3IuncB9Axhh1sr-2Btk2Uo-2BGi6HIwBi-2BhXZ1wAcKJsu2=
31Dbw7rmdKPaKrhuHFUOfTf2oHoK3UFjGJqXnj28IM4tUA3hjbSai0jxHlsbJVV-2F0mUQaAerN=
eUxyqYv70F-2F-2F6bq-2FIYKMfEPWzygU5FxekESwV2-2BLBoVvY9Jb81T1-2BNFrAfDKjPxUZ=
mhH-2FvxQ8swcBSmHTtkJTgBU-2BGoPWEF2OQwfbyedkAW3gT0AQdAE3b5hUd6WaQ-3D

** Disposals of own shares
------------------------------------------------------------

Brussels (Belgium), 20 November 2020 =E2=80=93 20:00 (CET) =E2=80=93 regula=
ted information

In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB SA/NV (=E2=80=9CUCB=E2=80=9D or the =
=E2=80=9CCompany) (Euronext Brussels: UCB) announces that, following exerci=
ses of stock options by members of its personnel, it has disposed of UCB sh=
ares OTC in view of deliveries of these shares to the relevant members of t=
he personnel, within the framework of the Long Term Incentive Program of th=
e UCB Group, as follows:

https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6ek0LDXk2-2B8BHiyhda-2BoCOnZMQdiSJbcht-2BmhmkxTCi2av8hRx=
G5xwHnpZfvxLMwxmrzgym2ZvSA0-2FjjRLTZk-2BmisAr9_xDPID0vOuylFAU8fv4e60wei4Jxq=
EGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2=
F2X9c9g1waQrs7SsLCPjFrUGj3IuncB9Axhh1sr-2Btk2Uo-2BGi6HIwBi-2BhXZ1wAcKJsu231=
Dbw7rmdKPaKrhuHFUOfTf2oHoK3UFjGJqXnj28IM4tUA3hjZ5A07B-2F5Bh5VHySTEjCOsdnXbQ=
PI-2FzhR-2B-2BkjmV8B30v35Q3Y2eeBP-2FTbwKtxE4sx-2FzQeeUF6egYWZcNzRdE4VBazO9l=
tQmKSY8u8ue7PFD5us7sahLYzjqR7t-2BrWxxIX6SDBgFwhqNpmDezi5Gyrkc-3D

This press release is available on UCB SA/NV=E2=80=99s website via the foll=
owing link (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQ=
yQ53jATUXZJD59ZUodhGC-2FyJVE-2BjXw-2Fd0j1C70r-2FZ058zOLCiGbx-2FzvKhSzxYKNx1=
8dK5MiuQ-3D-3D8Gri_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bS=
l0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waQrs7SsLCPjFrUGj3Iu=
ncB9Axhh1sr-2Btk2Uo-2BGi6HIwBi-2BhXZ1wAcKJsu231Dbw7rmdKPaKrhuHFUOfTf2oHoK3U=
FjGJqXnj28IM4tUA3hjVmcqz-2Bzes8XU73Rjzj1dbLjQjaAjMgn1ZSIuEZtRF-2BK7UagfztwS=
yAJNxwMazlZ7qSN0Tyl0mY21oJX2nAkndBp62p0LWXFovdZbqwoLlU5YMg5Bego1TnJ8f5O-2BC=
StV-2B-2Bp6TZU2kMISzoNI2Imd2c-3D .
=C2=A0
Investor Relations
Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0
Investor Relations, UCB
T +32.2.559.94.14 antje.witte@ucb.com

Isabelle Ghellynck,
=C2=A0Investor Relations, UCB
T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0

About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With 7 500 people in approxima=
tely 40 countries, the company generated revenue of =E2=82=AC 4.9 billion i=
n 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit=
ter: @UCB_news

GenericFile
201120 - Disposals of own shares (https://u7061146.ct.sendgrid.net/ls/click=
?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek0LDXk2-2B8BHiyhda-2=
BoCOnZBda4A9grmPlU4FU2f-2BW0ie2XAaO836iBXlvbKQgjP9o-3Dksbt_xDPID0vOuylFAU8f=
v4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeo=
COG9ekocVj-2F2X9c9g1waQrs7SsLCPjFrUGj3IuncB9Axhh1sr-2Btk2Uo-2BGi6HIwBi-2BhX=
Z1wAcKJsu231Dbw7rmdKPaKrhuHFUOfTf2oHoK3UFjGJqXnj28IM4tUA3hjd0QLdeZn7U-2F9Iq=
ahUr-2F26B4091s-2FPHkq8rPNrw5thV5ZLQ-2F77-2BV-2BFt4f67hirOvC2GWH0tsMU9HK238=
-2F3zbbXjsWr1OFJgozF-2Bms-2BsuClqi39YoUC40T0i-2FbNSa1tBzQGwAFvsDw2PTc-2F5MI=
BR0AOw-3D GenericFile
201120 - Ali=C3=A9nation d actions propres (https://u7061146.ct.sendgrid.ne=
t/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek0LDXk2-2B=
8BHiyhda-2BoCOnZ6ewQ989qgUs3cchsj1-2BoxfCTV6uI7UwzkE339sfD7Gk-3DwbZX_xDPID0=
vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB5=
2Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waQrs7SsLCPjFrUGj3IuncB9Axhh1sr-2Btk2Uo-2BGi6=
HIwBi-2BhXZ1wAcKJsu231Dbw7rmdKPaKrhuHFUOfTf2oHoK3UFjGJqXnj28IM4tUA3hjRs2Qv5=
KgIkD5qazPgR11hO9eBbDltoOyOaoExliYwg7SX1fLVcXdka8pJSBZvtkeAgKIn0w6T1xOHMy0O=
pSx-2FoNeDtjiK6hqSJvoNPsDlmmsSbRwPWOi3gt54BMzKGXtSihe5GLHU9g6YfXkZ5lWv0-3D =
GenericFile
201120 - Vervreemding van eigen aandelen (https://u7061146.ct.sendgrid.net/=
ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek0LDXk2-2B8B=
Hiyhda-2BoCOnZhWreT9cjMV87e2A9Y-2BGzmJkJtxCwxou19xhQMwKj394-3D3e27_xDPID0vO=
uylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Z=
lf-2FOeoCOG9ekocVj-2F2X9c9g1waQrs7SsLCPjFrUGj3IuncB9Axhh1sr-2Btk2Uo-2BGi6HI=
wBi-2BhXZ1wAcKJsu231Dbw7rmdKPaKrhuHFUOfTf2oHoK3UFjGJqXnj28IM4tUA3hjRrjJBo8n=
PonxTLm10xsNxYQItPv8v98lxeE6Q7SOmH-2FeyyU65ZyUJSlKg-2BGtU70euM3XL-2BcLEAiBD=
8axVVNrKBJeG9zMAXlZ3SkYX5Vugevz3VTBHKMZd3ybe5AbIaRE12rlWRW9pGOfeVkMDeqlW0-3=
D Image
Chart 1 Nov 20 2020 (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-=
2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek0LDXk2-2B8BHiyhda-2BoCOnZMQdiSJb=
cht-2BmhmkxTCi2amJqCY5rOaSy2DXR3frli5E-3Da0H0_xDPID0vOuylFAU8fv4e60wei4JxqE=
GBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F=
2X9c9g1waQrs7SsLCPjFrUGj3IuncB9Axhh1sr-2Btk2Uo-2BGi6HIwBi-2BhXZ1wAcKJsu231D=
bw7rmdKPaKrhuHFUOfTf2oHoK3UFjGJqXnj28IM4tUA3hjR23Nif3lhDYTwwDQN1pKz9oeRQYhM=
IpHjdbEayFC0t-2F-2BPizTjxwCNOe7JEtMpWSVIf7uQyAobTvNJVKqBfPcKTHvv86udB8cZeNS=
RL27ODaaTHlLfvP5jwE7BMmrcfD-2FzZ5tdq2RmTeuBKc6byT3ZA-3D=0D
=0D
______________________=0D
If you would rather not receive future communications from UCB SA, please g=
o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT=
UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcXIJH-2FOlnLC5slKdvhhl5v4zOx56JZO=
QeIGvr32TeU-2FK4vXHWlDMMC6bULw6QHal-2BrrW-2Bu3XWcMn0VJteiSG61SWLK6g8Ys9AWGL=
Q3Y2GX2S8-3DWX2T_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0=
KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waQrs7SsLCPjFrUGj3Iunc=
B9Axhh1sr-2Btk2Uo-2BGi6HIwBi-2BhXZ1wAcKJsu231Dbw7rmdKPaKrhuHFUOfTf2oHoK3UFj=
GJqXnj28IM4tUA3hjcRUV3rdvVni-2BgfjYmv70YlNXR7S9EkPw3EkYNYZPBNTqCVF5A1WAGahI=
uYqyw9Wkv4Pl6RQYsXBTzyrdV273H30edVAx7maNoxeVS9kJOkKs2cFU-2F-2FfbGHL0NCR7yMW=
FQlfjoAYusZnSmVpt-2B6ubzc-3D=0D
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=